Nasser H Hanna MD

Oncology•Indianapolis, IN

Associate Professor, Medicine, Indiana University School of Medicine

Join to View Full Profile

535 Barnhill Dr# ROUTE473Indianapolis, IN 46202
Phone+1 317-278-0054

Education & Training

Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1998 - 2000
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1995 - 1998
University of Missouri-Columbia School of MedicineClass of 1995

Certifications & Licensure

IN State Medical License 1999 - 2025
IA State Medical License 1995 - 1999
American Board of Internal Medicine Medical Oncology

Clinical Trials

Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma Start of enrollment: 2006 Feb 23
Completed
Phase 2
Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer Start of enrollment: 2002 Feb 01
Completed
Phase 3
Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer Start of enrollment: 2005 May 01
Completed
Phase 1, Phase 2
Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer Start of enrollment: 2005 Jan 01
Terminated
Phase 2
A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer Start of enrollment: 2006 Apr 01
Completed
Phase 2
Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas Start of enrollment: 2006 Apr 01
Completed
Phase 2
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jul 19
COMPLETED
PHASE3
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer Start of enrollment: 2006 Aug 01
Completed
Phase 2
Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer Start of enrollment: 2006 Oct 01
Completed
Phase 1, Phase 2
Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer Start of enrollment: 2007 Jun 01
Terminated
Phase 1, Phase 2
Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer Start of enrollment: 2008 Jan 01
Completed
Phase 2
Sutent + Taxol for Advanced Esophageal Cancer Start of enrollment: 2008 Aug 01
Completed
Phase 2
Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung Cancer Start of enrollment: 2009 Jan 01
Terminated
Phase 2
Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2010 Sep 21
ACTIVE_NOT_RECRUITING
PHASE2
Telephone Support Program for Lung Cancer Patients and Their Family Caregivers Start of enrollment: 2013 Mar 01
Completed
Not Applicable
Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer Start of enrollment: 2016 Jan 25
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Understanding the Dramatic Shift in Reported Lung Cancer Screening Rates: Methodologic Changes in the American Lung Association's State of Lung Cancer Report.
Peter R Gunderman, Zach Jump, Nasser Hanna
AJR. American Journal of Roentgenology. 2025-04-02
Correlates of Perceived Illness Severity and Terminality in Advanced Lung and Prostate Cancer.
Michaela Di Palmo, Ekin Secinti, Ellen Krueger, Nasser H Hanna, Nabil Adra
Journal of Pain and Symptom Management. 2025-04-01
Evaluation of Radiation Pneumonitis in a Phase 2 Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiat...
Michael Weisman, Greg Durm, Misty Dawn Shields, Nasser H Hanna, Sandra Althouse
International Journal of Radiation Oncology, Biology, Physics. 2025-03-01

Other

Adjuvant systemic therapy in resectable non-small cell lung cancer
Hanna N
http://www.uptodate.com/contents/adjuvant-systemic-therapy-in-resectable-non-small-cell-lung-cancer
UpToDate, Wolters Kluwer Health - 2013-03-25

Press Mentions

Doctors Urge More Smokers to Get Annual Lung Cancer ScreeningsMarch 8th, 2025
Honoring a Father’s Life and LegacyNovember 17th, 2022
Cancer Physician-Scientist Offers Expertise on New Lung Cancer CT Screening RecommendationsMarch 12th, 2021
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member